Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New approaches for biomarker discovery in lung cancer.

Expert review of molecular diagnostics - 1 Jan 2003

Valle Rosaura P C, Chavany Christine, Zhukov Tatyana A, Jendoubi Moncef

Abstract excerpt

Lung cancer remains the most common cause of cancer death in the US and worldwide. Currently, there is no implemented population-based screening for lung cancer. Of all the markers identified, none have achieved sufficient diagnostic significance to reach clinical application. Here we discuss the status of lung cancer early diagnostics, and the genomic and proteomic approaches currently undertaken for biomarker...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Sputum
Share to Proteomics
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Suppressor

Share to Heterogeneous-Nuclear Ribonucleoproteins

Share to Molecular Diagnostic Techniques

Share to Oligonucleotide Array Sequence Analysis

Share to Oncogenes

Source

Identifiers

PMID: 12528364
DOI: 10.1586/14737159.3.1.55

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New approaches for biomarker discovery in lung cancer.PMID 12528364Read ↗

Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesSemantic proximity Read ↗

Monoclonal antibodies in lung cancer.Semantic proximity Read ↗

Using Protein Microarray as a Diagnostic Assay for Non–Small Cell Lung CancerSemantic proximity Read ↗

Circulating Proteome for Pulmonary Nodule MalignancySemantic proximity Read ↗

Integral Protein Microarrays for the Identification of Lung Cancer Antigens in Sera That Induce a Humoral Immune ResponseSemantic proximity Read ↗

Development of Natural Protein Microarrays for Diagnosing Cancer Based on an Antibody Response to Tumor AntigensSemantic proximity Read ↗

Identification of a Biomarker Panel for Early Detection of Lung Cancer PatientsSemantic proximity Read ↗

Antibody-based proteomics: fast-tracking molecular diagnostics in oncologySemantic proximity Read ↗

Noninvasive lung cancer detection via pulmonary protease profilingSemantic proximity Read ↗

A multivariate cell-based assay for blood-based diagnostics enhances lung cancer risk stratificationSemantic proximity Read ↗

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early DetectionSemantic proximity Read ↗

A novel open access multimodal dataset of nodule imaging and circulating proteome from a lung cancer screening cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.